
Semaglutide Injection
From $109/mo
Provider-prescribed · 100% online
Compounded GLP-1 injections, needle-free oral options, and low-dose microdosing protocols, chosen by your provider, dispensed by licensed pharmacy channels, shipped to your door.



Compounded GLP-1 peptide therapy — injection, oral, and microdose — prescribed online by US-licensed providers. No insurance hoops, no chatbot triage.
GLP-1 (glucagon-like peptide-1) is a hormone involved in post-meal appetite, gastric emptying, and glucose signaling. Semaglutide and tirzepatide are prescription ingredients discussed in weight-management care, but every decision must identify the exact finished product and its evidence. Trial results for an FDA-approved branded product do not establish the safety or effectiveness of a patient-specific compounded preparation.
Peptide12 prescribes compounded GLP-1 medications in three forms: once-weekly semaglutide and tirzepatide injections, a daily oral semaglutide option for patients who would rather avoid needles, and low-dose microdosing protocols aimed at energy and tolerability. Compounded preparations are not FDA-approved finished drug products, and they are dispensed only under an individualized prescription after provider review. Every protocol is reviewed by a US-licensed prescribing provider, dispensed by state-licensed compounding pharmacies, and shipped overnight in temperature-controlled packaging. Browse the full menu of weight-loss peptide treatments.
STEP
1
Share your health profile online. A US-licensed provider reviews your fit and decides whether peptide therapy is right for you.

STEP
2
If approved, your custom prescription ships free and overnight in temperature-controlled packaging, arriving at your home.

STEP
3
Message your care team anytime for dose adjustments, check-ins, and ongoing support that keeps you progressing toward your goals.

Patients pick us for clinical rigor, transparent pricing, and care that doesn’t disappear after checkout.
Prescriptions are dispensed through licensed U.S. pharmacy channels or registered outsourcing facilities when applicable, with label, source, and quality-documentation questions handled before shipment.
Licensed providers in your state, not just an order form. Your provider titrates dosing and answers messages directly.
One flat price per protocol. No membership fees, no insurance hassle, no surprise charges. HSA and FSA accepted. Cancel anytime.
Message your care team through your patient portal whenever you need to. Most replies within hours, never longer than 24.
Clinical decision guides
Use these guides to prepare for provider review, especially when product status, medical history, medications, labs, pharmacy quality, or follow-up plans could change the prescription decision.
Review gastric sleeve, gastric bypass, nutrition labs, hydration risk, medication safety, and when bariatric follow-up is still needed.
Read guide →Ask how weight trend, side effects, refills, nutrition, and follow-up change after reaching a stable weight-management plan.
Read guide →Understand why A1C, CGM data, insulin, sulfonylureas, hypoglycemia history, and dehydration risk may change provider review.
Read guide →Use a provider-focused checklist for appetite changes, low intake, hydration, strength training, GI symptoms, and follow-up boundaries.
Read guide →Patient feedback on GLP-1 provider review, pharmacy sourcing, follow-up, and practical support.
Individual experiences vary and do not guarantee eligibility, prescription approval, symptom improvement, or a specific result.
“Down 42 lbs in 7 months on compounded semaglutide. The provider adjusted my dose three times based on how I was tolerating it — felt actually managed, not just shipped a vial.”
Yusuf B.
Boston, MA
“When cost became difficult, the care team reviewed a patient-specific compounded pathway with me, explained the different pharmacy label and instructions, and stayed available through the transition.”
Renee A.
Tampa, FL
“Tirzepatide. 38 pounds in 5 months, A1C from 6.7 to 5.6. Bloodwork ordered before I started, again at 90 days. Real protocol, not a vending machine.”
Mason F.
Salt Lake City, UT
“The oral option meant I never had to deal with needles. Intake on a Sunday, provider review Monday, medication in hand that week. Provider replied to messages same day, twice.”
Ines L.
Charlotte, NC
“Finished my titration on compounded tirzepatide, transitioned to a maintenance dose. Lost 34 lbs total. My provider walked me through the maintenance plan before I asked.”
Theo R.
Portland, OR
“First GLP-1. The licensed provider spent 20 minutes on the intake video call walking through side effects and what to watch for. Started low, no nausea, easy ramp up.”
Kira N.
Nashville, TN
It depends on clinical eligibility, goals, medical history, route preference, formulation-specific evidence, and what the prescribing provider determines is appropriate. Compounded injections, a compounded sublingual option, and low-dose compounded protocols have different formulations, instructions, evidence limits, and follow-up needs. None is an FDA-approved finished drug product, and results from an approved branded product should not be assigned to a compounded option. Your provider will help you compare.
There is no guaranteed rate or amount of weight change. Results from trials of FDA-approved branded products do not establish results for a patient-specific compounded preparation. Your provider will set individualized goals and review weight trend, appetite, tolerance, nutrition, activity, medical history, and whether treatment remains appropriate.
FDA-approved branded products have manufacturer-specific formulations, indications, presentations, labels, and instructions. A patient-specific compounded prescription follows a separate prescriber-and-pharmacy pathway and may differ in formulation, concentration, inactive ingredients, container, storage, beyond-use date, and dosing instructions. It is not an FDA-approved finished drug product, generic, equivalent, or interchangeable substitute.
Peptide12 uses state-licensed compounding-pharmacy channels for individualized prescriptions. Patients should receive a pharmacy label identifying the formulation, concentration, directions, storage, beyond-use date, and dispensing pharmacy. Compounded medications are not FDA-approved finished drug products, and pharmacy testing or documentation does not establish branded-product equivalence.
Yes. Baseline labs (metabolic panel, HbA1c, lipid panel, thyroid panel) are reviewed by your prescribing provider before a prescription is issued. Recent labs (within 12 months) can be uploaded; otherwise we coordinate at-home or in-network draws.
Stopping or changing a compounded prescription should be planned with the prescribing provider. The provider can review weight trend, appetite, side effects, medical history, nutrition, activity, and follow-up needs. Withdrawal findings from an FDA-approved branded-product trial should not be presented as established outcomes for a compounded preparation.
Yes. There are no minimum commitments. You can pause or cancel before your next shipment from your patient portal or by messaging your care team.
From compounded GLP-1 injections to oral and microdose protocols — one care team, one prescribing provider, one transparent price.
Information for educational purposes only. Eligibility, dosing, and treatment decisions are made by a US-licensed prescribing provider based on your medical history. Compounded medications are not FDA-approved as finished drug products and are prepared through licensed pharmacy channels under individualized prescription.
